- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · May 12, 2025 | 6.91M sh |
| Cash And Equivalents | Q2 2025 · Mar 30, 2025 | $3.53M |
| Cash And Equivalents | Q2 2025 · Sep 29, 2024 | $1.01M |
| Current Liabilities | Q2 2025 · Mar 30, 2025 | $4.41M |
| Current Liabilities | Q2 2025 · Sep 29, 2024 | $4.95M |
| Total Liabilities | Q2 2025 · Mar 30, 2025 | $5.89M |
| Total Liabilities | Q2 2025 · Sep 29, 2024 | $6.71M |
| Current Assets | Q2 2025 · Mar 30, 2025 | $22.28M |
| Current Assets | Q2 2025 · Sep 29, 2024 | $20.07M |
| Total Assets | Q2 2025 · Mar 30, 2025 | $27.48M |
| Total Assets | Q2 2025 · Sep 29, 2024 | $25.52M |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 6.82M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 6.77M sh |
| Capex | Q2 2025 · Mar 31, 2024 | $167K |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | $978K |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $16.46M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $15.38M |
| Stockholders Equity | Q2 2025 · Oct 1, 2023 | $14.86M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.16 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.22 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.16 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.22 |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $1.2M |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $2.33M |
| Net Income | Q2 2025 · Mar 31, 2024 | $1.06M |
| Net Income | Q2 2025 · Mar 31, 2024 | $1.49M |
| Operating Income | Q2 2025 · Mar 31, 2024 | $1.36M |
| Operating Income | Q2 2025 · Mar 31, 2024 | $1.91M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $2.56M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $4.24M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $5.97M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $11.25M |
| Revenue | Q2 2025 · Mar 31, 2024 | $8.52M |
| Revenue | Q2 2025 · Mar 31, 2024 | $15.49M |